Article
Performance of LFSPRO prediction in TP53 mutation status for prospectively collected probands.
American journal of human genetics - 7 May 2026
Corredor Jessica L, Li Ruonan, Dodd-Eaton Elissa B, Casey Jacynda, Woodson Ashley H, Nguyen Nam H, Peng Gang, Gutierrez Angelica M, Arun Banu K, Wang Wenyi
Abstract excerpt
Genetic counseling and testing for germline mutations are essential for identifying individuals at increased risk for cancer. Pathogenic/likely pathogenic (P/LP) variants in TP53 are diagnostic of Li-Fraumeni syndrome (LFS), a highly penetrant disorder with diverse, early-onset tumors. Current clinical guidelines, such as Chompret and classic criteria, provide frameworks for identifying individuals at risk for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
